Catalyst Wire Dossier Catalyst Wire Dossier

611 (Formulation A)

611 · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 611 (Formulation A), covering 2025-06-27 to 2025-06-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Two Different Formulations of 611 in Healthy Adult Subjects in China [Phase 1]

See pricing